CREATE Medicines
Last verified 2026-05-21. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $122.0Mattributed |
|---|---|
| Latest round | series-b, $122.0M, 2026-05-14attributed |
| Founded | 2020 |
| Headquarters | Cambridge, USA |
| Industry | healthtech |
| Stage | series-b+ |
| Website | createmedicines.com |
CREATE Medicines is a drug discovery company using machine learning to design small-molecule therapies for genetically validated targets in oncology and rare disease. Its proprietary generative chemistry platform iterates compound design and synthesis prediction in silico before any wet-lab work begins.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-05-14 | series-b | $122.0M | undisclosed |
Detected tech stack
Netlify, Next.js, React, Webpack
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $122.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $122.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | createmedicines.com, read 2026-05-21 |
| Description | self-reported | createmedicines.com, read 2026-05-21 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.